PREEMPTIVE RITUXIMAB TREATMENT MAY REDUCE THE INCIDENCE OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) IN PATIENTS WITH EBV REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

被引：1
|
作者：
Kindwall-Keller, T. L. [1 ]
Cooper, B. W. [1 ]
Laughlin, M. J. [1 ]
Gerson, S. L. [1 ]
Barr, P. [1 ]
Erinc, S. [1 ]
Creger, R. J. [1 ]
Lazarus, H. M. [1 ]
机构：
[1] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.282
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
250
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [1] Rituximab in treatment of post-transplant lymphoproliferative disease after allogeneic stem cell transplantation
    Gil, Lidia
    Styczynski, Jan
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2011, 15 (03): : 155 - 158
  • [2] EBV - Post Transplant Lymphoproliferative Disorders (PTLD) following allogeneic transplantation
    Sakellari, I
    Athanasiou, E
    Topalidou, M
    Papadakis, E
    Dourvas, G
    Sotiropoulos, D
    Anagnostopoulos, A
    Fassas, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S139 - S139
  • [3] Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
    Clerico, Michele
    Dogliotti, Irene
    Aroldi, Andrea
    Consoli, Chiara
    Giaccone, Luisa
    Bruno, Benedetto
    Cavallo, Federica
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [4] Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
    Ding-Bao Chen
    Qiu-Jing Song
    Yun-Xin Chen
    Yu-Hong Chen
    Dan-Hua Shen
    International Journal of Hematology, 2013, 97 : 117 - 124
  • [5] Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
    Chen, Ding-Bao
    Song, Qiu-Jing
    Chen, Yun-Xin
    Chen, Yu-Hong
    Shen, Dan-Hua
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (01) : 117 - 124
  • [6] The Effect of Preemptive Rituximab Treatment in Patients with EBV Viremia after Solid Organ Transplantation on the Development of Post-Transplant Lymphoproliferative Disorder
    Orlando, Elevelyn H.
    Gould, Patrick
    Cuzzo, Brian
    Ford, Maegan
    Chen, Yuxuan
    Sanjurjo, Alexander
    May, Benjamin
    Tsapepas, Demetra
    Leeman-Neill, Rebecca J.
    Bhagat, Govind
    Dube, Geoffrey
    Morris, Heather
    Arcasoy, Selim
    Latif, Farhana
    Martinez, Mercedes
    Pereira, Marcus
    Lipsky, Andrew H.
    Sawas, Ahmed
    Reshef, Ran
    Pro, Barbara
    Cherng, Hua-Jay J.
    Amengual, Jennifer E.
    BLOOD, 2023, 142
  • [7] Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients
    Reddy, Nishitha
    Rezyani, Katayoun
    Barrett, A. John
    Savani, Bipin N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 591 - 597
  • [8] Post-transplant lymphoproliferative disease (PTLD): high incidence after non-T-cell-depleted allogeneic stem cell transplantation
    Juvonen, E
    Aalto, S
    Volin, L
    Ruutu, T
    Tarkkanen, J
    Piiparinen, H
    Hedman, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S27 - S28
  • [9] Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant
    Rodriguez, Lizamarie Bachier
    Shore, Tsiporah B.
    Gergis, Usama
    Hsu, Jingmei
    Phillips, Adrienne A.
    Mayer, Sebastian A.
    Rennert, Hanna
    Van Besien, Koen
    BLOOD, 2017, 130
  • [10] Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report
    Bay, J. -O.
    de latour, R. Peffault
    Bruno, B.
    Coiteux, V.
    Guillaume, T.
    Hicheri, Y.
    Paillard, C.
    Suarez, F.
    Turlure, P.
    Alain, S.
    Bulabois, C. -E.
    Socie, G.
    Bauters, F.
    Yakoub-Agha, I.
    PATHOLOGIE BIOLOGIE, 2013, 61 (04): : 152 - 154
12345